Overview
Nayyar Syed is an Oncologist and a Hospital Medicine provider in Dallas, Texas. Dr. Syed is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Tumor. Dr. Syed is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7777 Forest Ln, Suite D110, Dallas, TX 75230
University Of Texas Southwestern Medical Center At Dallas
Taha Bat is a Hematologist and an Oncologist in Dallas, Texas. Dr. Bat is rated as a Distinguished provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Hepatic Porphyria (AHP), and Porphyria.
University Of Texas Southwestern Medical Center At Dallas
Ibrahim Ibrahim is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Ibrahim is rated as a Distinguished provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Essential Thrombocythemia, Shwartzman Phenomenon, Venous Thromboembolism (VTE), Hereditary Hemorrhagic Telangiectasia, and Bone Marrow Aspiration.
University Of Texas Southwestern Medical Center At Dallas
John Hancock is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Hancock is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Prothrombin Deficiency, Shwartzman Phenomenon, Venous Thromboembolism (VTE), Endoscopy, and Stent Placement. Dr. Hancock is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone TumorDr. Syed isDistinguished. Learn about Bone Tumor.
- Lung CancerDr. Syed isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Syed isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Syed isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Adult Soft Tissue SarcomaDr. Syed isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Syed isAdvanced. Learn about Anemia.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Experienced
- Adrenal CancerDr. Syed isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Syed isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Syed isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Syed isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Syed isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Syed isExperienced. Learn about Angiosarcoma.